BRIAN MEHLING, MD TO PRESENT SPINAL CORD STEM CELL RESEARCH AT ANNUAL MEETING OF THE SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS
Brian Mehling, MD has been invited to present his research at the 17th Annual World Congress of the Society for Brain Mapping and Therapeutics being held at the JW Marriott, in Los Angeles, California from Friday March 20-Sunday March 22. The conference will bring together physicians, scientists, policy makers, funding agencies and industry to further the advances and applications in brain and spinal cord mapping and image guided therapies (operative and non-operative). Dr. Mehling is the founder and chief medical officer of BHI...
read moreWORLD-RENOWNED STEM CELL RESEARCHER AND BOARD-CERTIFIED SURGEON, DR. BRIAN MEHLING, SET TO ATTEND THE 50TH ANNUAL WORLD ECONOMIC FORUM IN DAVOS
The 2020 World Economic Forum (WEF) in Davos will explore the ideas, innovations and discoveries that are reshaping our world by working closely with those in the vanguard of change from such fields as the arts, culture, engineering, media, medicine, science, and technology.The US-based company BHI Therapeutic Sciences (BHITS) represented by Brian Mehling, MD, Founder and Chief Medical Officer; Klara Doert, President of International Business Development; Katarina Novakova, MSc, President of BHI Slovakia ; Alan...
read moreBRIAN MEHLING, MD AND BHI THERAPEUTIC SCIENCES TO PRESENT RESEARCH AT AAOS ANNUAL MEETING
Orthopedic surgeon Brian Mehling, MD and his research team at BHI Therapeutic Sciences will exhibit at the American Academy of Orthopedic Surgeons 2020 Annual Meeting, March 24 – 28, at the Orange County Convention Center in Orlando, Florida. The team will present the results of their study entitled “Adipose Tissue-Derived Stromal Vascular Fraction Cells Application in Subjects with Osteoarthritis and Rheumatoid Arthritis: Retrospective Chart Review Study.” Their results will be presented at booth #1004 located in the West Concourse of...
read moreBlue Horizon International Ambassador Lance Palmer becomes PFL’s first multi-millionaire
On December 31, 2019, Lance Palmer celebrated the new year by defeating Alex Gilpin in a unanimous decision win at Madison Square Garden. The victory gave Palmer the featherweight title for the second year in a row, and another million dollars.Palmer—a former All-American wrestler and current MMA champion in the Featherweight Division—credits stem cell treatments from Blue Horizon International (BHI) with a greater feeling of overall health and energy, and more rapid recovery from training. Palmer received his treatments at the BHI...
read moreBlue Horizon International exhibits at World Congress on Anti-Aging Medicine in Las Vegas
Blue Horizon International (BHI), Alpha Blu Skin Care, BHI Therapeutic Sciences, and BHI Rejuve participated in the 27th World Congress on Anti-Aging Medicine & Exhibition in Las Vegas, December 13-15, 2019. Brian Mehling, M.D. , Founder and Chief Medical Officer of BHI was joined by Klara Doert, President of International Business Development; Katarina Novakova, Director of Relations; Alan DaSilvaPereira, President of BHI Brazil; Fidel Desmar, Clinical Research Coordinator; Ralph Moffetone and John-David Grayson from Industrial Motion...
read moreBlue Horizon International Ambassador Lance “the Party” Palmer is ready to party on New Years Eve in Madison Square Garden in NYC
Lance Palmer will be facing Alex Gilpin on December 31, 2019 at the Madison Square Garden in New York City. The fight will air at 7 p.m. EST on ESPN 2. Palmer—a former All-American wrestler and current MMA champion in the Featherweight Division—credits stem cell treatments from Blue Horizon International (BHI) with a greater feeling of overall health and energy, and more rapid recovery from training. Palmer received his treatments at the BHI Jamaica, Montego Bay Clinic. “My first stem cell treatment was in 2016,” says Palmer....
read moreBRIAN MEHLING, MD AND MARINA MANVELYAN, PH.D RECEIVE MEMBERSHIP TO THE PRESTIGIOUS INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH
Hackensack, NJ – BHI Therapeutic Sciences is pleased to announce that Brian Mehling, MD, Chief Medical Officer and Marina Manvelyan, Ph.D., Clinical Research Scientist have been accepted as members of the prestigious International Society for Stem Cell Research (ISSCR). Members of the ISSCR have been sharing global stem cell science for more than 15 years. With roughly 4,000 members from more than 60 countries, the ISSCR is the pre-eminent global, cross-disciplinary, science-based organization dedicated to stem cell research and its...
read moreBlue Horizon International CEO Recognized by the International Nurses Association
Doreen Santora, RN, MPH, chief executive officer of Blue Horizon International, will be recognized as a top nurse by the International Nurses Association and will be featured in the publication Worldwide Leaders in Healthcare. Ms. Santora is receiving this honor for her outstanding acheivements, commitment to education, and demonstrated leadership in her field. “I am grateful to be recognized by the International Nurses Association,” said Ms. Santora. “It is always nice to be recognized, but when you are honored by...
read moreIFBB Pro Champion Anton Antipov Hosts Podcast with Dr. Brian Mehling
On August 2nd, 2019 IFBB Pro Champion and professional fitness model Anton Antipov hosts the podcast Gee Talks, and recently had Dr. Brian Mehling on as a guest to have a long, wide-ranging discussion about the potential of stem cell science. Antipov has received three stem cell treatments from Dr. Mehling, once in the BHI clinic in Bratislava, Slovakia, and twice in the new Montego Bay, Jamaica clinic, and intends to receive...
read moreLiving Cells
Live stems cells and primary cells. these images are slices from a 3D hologram made by recording cell density and there is no labelling from LivingCells Live stem cells and primary cells
read more
